James River Group Announces Management Shift
Mr. Abram commented, “The Company has performed extremely well under Bob’s skillful leadership. Indeed, the results from our most recent quarter demonstrate his success as CEO. However, lingering effects from a case of Lyme disease make it impossible for Bob to perform all the duties of CEO to his satisfaction. In consultation with the Board of Directors, he has asked me to return as CEO. Bob and I, and the broader management team, have worked together in this configuration before, and we return to this arrangement with confidence. Our focus will remain on continuing to seek to deliver strong underwriting results, profitable growth and earning industry leading returns on equity.”
“I have enjoyed being CEO of James River and have great confidence in our future,” Mr. Myron said. “I look forward to working with Adam and our team to build on our momentum.”
For more information contact:
Kevin CopelandSVP Finance & Chief Investment Officer Investor Relations 441-278-4573 InvestorRelations@jrgh.net
Source: James River Group Holdings, Ltd.